Tops Holding II Corporation Reports First Quarter 2016

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Tops Holding II Corporation Reports First Quarter 2016 Results
  • Inside sales of $678.1 million in the first quarter, up $1.4 million over prior-year period
  • First quarter Adjusted EBITDA increased 4.6% to $37.1 million
  • Added two supermarket locations since year-end

WILLIAMSVILLE, N.Y., June 01, 2016 (GLOBE NEWSWIRE) -- Tops Holding II Corporation (“Tops” or the “Company”), the indirect parent of Tops Markets, LLC (“Tops Markets”), a leading supermarket retailer serving Upstate New York, Northern Pennsylvania and Vermont, today reported financial results for the first quarter ended April 23, 2016.

“We continued to perform well given the strong deflationary headwinds that persist to affect supermarket operators industrywide,” commented Frank Curci, Tops Chairman and CEO.  “Inside sales were up slightly in the quarter and Adjusted EBITDA, which excludes non-recurring items, increased almost 5%.  More importantly, Tops’ market share remains very strong as we have recently achieved some of our best results in several years with gains in our leading markets.  We added one supermarket in Westfield, Pennsylvania during the quarter and opened another location in Sanborn, New York in late April.  Both locations are performing exceptionally well in their smaller footprints.”

Mr. Curci added, “While we do not see food cost deflation abating significantly in the near future, our strong market share positions us very well to capitalize when the recent macroeconomic challenges begin to recede.  We continue to employ marketing initiatives that increase customer loyalty and drive traffic, including our popular Price-Lock guarantee program and the return of our Monopoly promotion in the second quarter.  We are also in the process of relaunching our private label program, with redesigned packaging, new marketing programs, and increased offerings in natural and organic categories which should contribute positively to gross margin.  These initiatives, combined with fill-in acquisitions to our supermarket portfolio and continued effective cost controls, are expected to mitigate the challenge of food cost deflation.”

Fiscal 2016 First Quarter Financial Results

Inside sales were $678.1 million in the first quarter of 2016 (16-week period), up $1.4 million from the 2015 first quarter (16-week period), which reflects the $16.6 million incremental contribution from six acquired and new supermarkets opened since May 2015, partially offset by a $2.4 million decrease in sales attributable to the 27 in-store pharmacies closed in January 2015.  Same store sales, which exclude the sales of the 27 closed in-store pharmacies and franchise revenue, decreased 1.5% in the first quarter on a comparable 16-week basis due to food cost deflation in certain categories, primarily in meat and dairy, combined with competitive pressure to respond with lower prices.

Fuel sales were negatively impacted by a 22.0% decline in the average retail price paid per gallon, and as a result, were $35.6 million in the first quarter, a decrease of $10.5 million, or 22.8%, from the prior-year period.  As of April 23, 2016, 52 corporate fuel stations were in operation.

Overall, first quarter net sales decreased $9.1 million, or 1.3%, to $713.7 million.

Gross profit for the first quarter was $215.1 million, or 30.1% of net sales, up 40 basis points over the 2015 first quarter.  The margin improvement was due to product mix given the smaller proportion of lower margin fuel sales, and $2.2 million in incremental savings associated with the amendment of certain operating terms of our agreement with C&S Wholesale Grocers, Inc. effective April 1, 2015.  Although fuel profitability in the first quarter of 2016 was stable despite increasing commodity costs, unusual profitability during the first quarter of 2015 drove a $2.4 million decline in period-over-period fuel gross profit.

Total operating expenses were $204.7 million, a $12.4 million increase from $192.4 million in the prior-year period.  Most of the variance was attributable to the favorable impact of an $11.0 million gain from the sale of pharmacy scripts and inventory during the 2015 period.  Other major factors driving operating expenses in the quarter include:

  • Lower selling and general expenses due to decreased utility costs, in part due to warmer than normal weather in the 2016 first quarter
  • Higher administrative expenses tied to $2.1 million of legal and professional fees related to the ongoing dispute and associated arbitration proceeding with the New York State Teamsters Conference Pension and Retirement Fund, normal wage adjustments and higher associate health care costs, partially offset by a $1.1 million decrease in performance-based bonus expense
  • Higher rent expenses due to new supermarket and fuel locations opened since May 1, 2015
  • Increased depreciation expense related to capital investments made in 2015 and 2016

As a percentage of net sales, wages, salaries and benefits, which represent the largest component of the Company’s operating expenses, were consistent with the 2015 first quarter.

Operating income for the 2016 first quarter was $10.3 million compared with $22.1 million in the 2015 first quarter, which included the $11.0 million gain on sale of the pharmacy assets.

Interest expense for the quarter was $24.9 million, a decrease of $0.9 million due to the reduction in interest costs that resulted from the June 2015 debt refinancing.  Net loss for the 2016 first quarter was $15.2 million compared with a net loss of $4.2 million in the first quarter of 2015.

Supplemental Reporting on EBITDA and Adjusted EBITDA

To provide investors with greater understanding of its operating performance, in addition to reporting results in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”), Tops provides supplemental reporting on EBITDA and Adjusted EBITDA, both non-GAAP measures.

First quarter 2016 EBITDA was $33.9 million compared with $44.2 million in the first quarter of 2015.  Adjusted EBITDA, which excludes specified non-cash and nonrecurring items including the gain on sale of pharmacy assets in the first quarter of 2015, was $37.1 million, up $1.6 million, or 4.6%, from $35.5 million in the prior-year period.

See “Non-GAAP Financial Measures” below for a discussion of EBITDA and Adjusted EBITDA, and the attached table for a reconciliation to GAAP net loss.

Liquidity

Cash and cash equivalents were $33.0 million at April 23, 2016, compared with $35.6 million at January 2, 2016.  Cash provided by operating activities during the first quarter was $10.4 million, a decrease of $20.2 million from the prior-year period.  The decrease in cash generated primarily reflects an $8.9 million increase in the payout of bonuses in the 2016 first quarter and $3.2 million of cash proceeds received in the first quarter of 2015 related to the sale of pharmacy inventory from 27 of our in-store pharmacies.  Additionally, there was an increase in inventory in the 2016 first quarter to replenish lower than normal levels at 2015 year-end, in part due to the fiscal year-end falling after the New Year's Day holiday, and other working capital timing differences.

Cash provided by operating activities supported growth initiatives, including $8.7 million in capital expenditures that were largely related to new store openings, store remodels and maintenance activities.  The Company anticipates investing between $35 million and $40 million in capital expenditures in 2016.

As of April 23, 2016, total debt excluding capital leases was $685.9 million compared with $683.4 million at 2015 year-end.  Outstanding borrowings under the Company’s revolving credit facility were $48.9 million as of April 23, 2016.  The unused availability under the revolving credit facility was $36.4 million after giving effect to the borrowing base calculation and $22.8 million of letters of credit outstanding.  Tops expects that cash generated from operations and availability under the revolving credit facility will provide sufficient liquidity to fund debt service requirements, investments in working capital, capital expenditures, acquisitions and other cash requirements for at least the next twelve months.

Conference Call Details

Tops will host a conference call on Thursday, June 2, 2016, beginning at 11:00 a.m. Eastern Time.  During the call, management will review the financial and operating results for the 2016 first quarter, and discuss Tops’ corporate strategy and outlook.  A question-and-answer session will follow.  The conference call can be accessed by dialing (201) 689-8560.

A telephonic replay will be available from 2:00 p.m. ET the day of the teleconference until Thursday, June 16, 2016.  To listen to the replay, dial (858) 384-5517 and enter replay pin number 13636026.

About Tops Holding II Corporation

Tops is the parent of Tops Holding LLC and the indirect parent of Tops Markets, LLC, which is headquartered in Williamsville, NY, and operates 165 corporate full-service supermarkets, 164 under the Tops banner and one under the Orchard Fresh banner, with an additional five supermarkets operated by franchisees under the Tops banner.  With approximately 14,200 associates, Tops is a leading full-service grocery retailer in Upstate New York, Northern Pennsylvania and Vermont.  Tops’ strategy is to build on its solid market share in the areas it operates by continuing to differentiate itself from competitors by offering quality products at affordable prices with superior customer service and by remaining an integral part of the community.

For more information about Tops Markets, visit the company's website at www.topsmarkets.com .

Safe Harbor Statement The information made available in this news release contains forward-looking statements, which are generally statements about future events, plans, objectives and performance.  Generally, the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “project,” “will” and similar expressions identify forward-looking statements.  Forward-looking statements reflect our current expectations, based on currently available information, and are not guarantees.  Although we believe that the expectations reflected in such forward-looking statements are reasonable, these expectations could prove inaccurate as such statements involve risks and uncertainties, many of which are beyond our ability to control or predict.  Should one or more of these risks or uncertainties, or other risks or uncertainties not currently known to us or that we currently deem to be immaterial, occur, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected.  Important factors relating to these risks and uncertainties include, but are not limited to the following:

  • current economic conditions and the impact on consumer demand and spending and our pricing strategy;
  • pricing and market strategies, the expansion, consolidation and other activities of competitors, and our ability to respond to the promotional practices of competitors;
  • our ability to effectively increase or maintain our profit margins;
  • the success of our store acquisition, construction and remodel programs;
  • fluctuations in utility, fuel and commodity prices which could impact consumer spending and buying habits and the cost of doing business;
  • risks inherent in our fuel station operations;
  • our exposure to local economies and other adverse conditions due to our geographic concentration;
  • risks of natural disasters and severe weather conditions;
  • supply problems with our suppliers and vendors;
  • our relationships with unions and unionized employees, and the terms of future collective bargaining agreements or labor strikes;
  • increased operating costs resulting from increases in the minimum wage, rising employee benefit costs or pension funding obligations;
  • changes in, or the failure or inability to comply with, laws and governmental regulations applicable to the operation of our pharmacy and other businesses;
  • the adequacy of our insurance coverage against claims of our customers in connection with our pharmacy services;
  • estimates of the amount and timing of payments under our self-insurance policies;
  • risks of liability under environmental laws and regulations;
  • our ability to maintain and improve our information technology systems;
  • events that give rise to actual or potential food contamination, drug contamination or food-borne illness or any adverse publicity relating to these types of concerns, whether or not valid;
  • threats or potential threats to security;
  • our ability to retain key personnel;
  • risks of data security breaches or losses of confidential customer information;
  • risks relating to our substantial indebtedness;
  • claims or legal proceedings against us; and
  • other factors discussed under “Risk Factors” in our Annual Report on Form 10-K for Fiscal 2015.

We caution that investors should not place undue reliance on forward-looking statements, which speak only as of the date on which they are made.  We disclaim any intention, obligation or duty to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Non-GAAP Financial Measures

In addition to reporting financial results in accordance with GAAP, we provide information regarding EBITDA and Adjusted EBITDA.  We define EBITDA as earnings before interest, taxes, depreciation and amortization.  We define Adjusted EBITDA as EBITDA adjusted to exclude certain non-cash items and items that are not indicative of our core operating performance.  We use EBITDA and Adjusted EBITDA to evaluate our operating performance and liquidity, and they are among the primary measures used by management for planning and forecasting for future periods.  We believe the presentation of these measures is relevant and useful for investors because it allows investors to view results in a manner similar to the method used by management and, with respect to EBITDA, makes it easier to compare our results with other companies that have different financing and capital structures.  See the last table of this release for a reconciliation of EBITDA and Adjusted EBITDA to the most directly comparable GAAP financial measure, which we believe is net loss.

FINANCIAL TABLES FOLLOW.

TOPS HOLDING II CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
 (Dollars in thousands)
(Unaudited)
 
    16-week periods ended                    
    April 23, 2016     April 18, 2015     $ Change     % Change    
Net sales   $ 713,736     $ 722,850     $ (9,114 )     (1.3 )%  
Cost of goods sold     (486,866 )     (494,125 )     7,259       1.5 %  
Distribution costs     (11,814 )     (14,260 )     2,446       17.2 %  
Gross profit     215,056       214,465       591       0.3 %  
                                   
Operating expenses:                                  
Wages, salaries and benefits     (107,833 )     (109,456 )     1,623       1.5 %  
Selling and general expenses     (36,505 )     (37,802 )     1,297       3.4 %  
Administrative expenses (inclusive of share-                                  
based compensation expense of $89 and $69)     (25,470 )      (23,493 )      (1,977 )     (8.4 )%   
Rent expense, net     (8,601 )     (8,197 )     (404 )     (4.9 )%  
Depreciation and amortization     (19,915 )     (18,606 )     (1,309 )     (7.0 )%  
Advertising     (6,424 )     (5,835 )     (589 )     (10.1 )%  
Gain on sale of assets     —       11,014       (11,014 )     (100.0 )%  
Total operating expenses     (204,748 )     (192,375 )     (12,373 )     (6.4 )%  
Operating income     10,308       22,090       (11,782 )     (53.3 )%  
Interest expense, net     (24,887 )     (25,743 )     856       3.3 %  
Loss before income taxes     (14,579 )     (3,653 )     (10,926 )     (299.1 )%  
Income tax expense     (571 )     (542 )     (29 )     (5.4 )%  
Net loss   $ (15,150 )   $ (4,195 )   $ (10,955 )     (261.1 )%  

TOPS HOLDING II CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in thousands, except share and per share amounts)
(Unaudited)
 
    April 23, 2016     January 2, 2016  
Assets                
Current assets:                
Cash and cash equivalents   $ 33,007     $ 35,557  
Accounts receivable, net     60,509       68,198  
Inventory, net     144,703       141,223  
Prepaid expenses and other current assets     14,175       16,857  
Total current assets     252,394       261,835  
Property and equipment, net     361,063       369,446  
Goodwill     213,096       213,096  
Intangible assets, net     170,452       173,730  
Other assets     13,472       11,547  
Total assets   $ 1,010,477     $ 1,029,654  
                 
Liabilities and Shareholders' Deficit                
Current liabilities:                
Accounts payable   $ 73,306     $ 81,812  
Accrued expenses and other current liabilities     98,095       96,757  
Current portion of capital lease obligations     9,188       8,566  
Current portion of long-term debt     2,407       2,075  
Total current liabilities     182,996       189,210  
Capital lease obligations     142,293       143,122  
Long-term debt, net     683,469       681,372  
Other long-term liabilities     46,654       44,680  
Non-current deferred tax liabilities     44,239       43,694  
Total liabilities     1,099,651       1,102,078  
                 
Common stock ($0.001 par value; 300,000 authorized shares, 126,560                
shares issued and 126,559 shares outstanding as of April 23, 2016                
and January 2, 2016)     —       —  
Treasury stock (at cost; 1 share as of April 23, 2016 and January 2, 2016)     (1 )     (1 )
Paid-in capital     6,374       7,974  
Accumulated deficit     (93,942 )     (78,792 )
Accumulated other comprehensive loss, net of tax     (1,605 )     (1,605 )
Total shareholders' deficit     (89,174 )     (72,424 )
Total liabilities and shareholders' deficit   $ 1,010,477     $ 1,029,654  

TOPS HOLDING II CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 (Dollars in thousands)
(Unaudited)
 
    16-week periods ended  
    April 23, 2016     April 18, 2015  
Cash flows provided by operating activities:                
Net loss   $ (15,150 )   $ (4,195 )
Adjustments to reconcile net loss to net cash provided by operating activities:                
Depreciation and amortization     23,614       22,118  
Amortization of deferred financing costs     731       1,298  
Deferred income taxes     545       540  
LIFO inventory valuation adjustments     369       202  
Straight-line rent adjustment     266       309  
Share-based compensation expense     89       69  
Gain on sale of assets     —       (11,014 )
Other     153       341  
Changes in operating assets and liabilities:                
Decrease in accounts receivable     7,689       2,838  
(Increase) decrease in inventory, net     (3,849 )     7,327  
Decrease (increase) in prepaid expenses and other current assets     2,682       (3,349 )
Increase in other assets     (1,925 )     —  
Decrease in accounts payable     (7,427 )     (100 )
Increase in accrued expenses and other current liabilities     863       13,845  
Increase in other long-term liabilities     1,799       384  
Net cash provided by operating activities     10,449       30,613  
Cash flows (used in) provided by investing activities:                
Cash paid for property and equipment     (8,685 )     (9,934 )
Cash proceeds from sale of assets     413       11,255  
Net cash (used in) provided by investing activities     (8,272 )     1,321  
Cash flows used in financing activities:                
Borrowings on 2017 ABL Facility     293,000       126,500  
Repayments on 2017 ABL Facility     (290,800 )     (148,500 )
Principal payments on capital leases     (2,644 )     (2,791 )
Repayments of long-term debt borrowings     (2,043 )     (647 )
Dividends to Tops MBO Corporation     (2,015 )     (775 )
Change in bank overdraft position     (551 )     (218 )
Capital contribution     326       —  
Purchase of treasury stock     —       (1 )
Net cash used in financing activities     (4,727 )     (26,432 )
Net (decrease) increase in cash and cash equivalents     (2,550 )     5,502  
Cash and cash equivalents–beginning of period     35,557       26,316  
Cash and cash equivalents–end of period   $ 33,007     $ 31,818  

TOPS HOLDING II CORPORATION
RECONCILIATION OF GAAP NET LOSS TO EBITDA AND ADJUSTED EBITDA
 (Dollars in thousands)
(Unaudited)
                   
                   
    16-week periods ended    
    April 23, 2016     April 18, 2015    
Net loss   $ (15,150 )   $ (4,195 )  
Depreciation and amortization     23,614       22,118    
Interest expense     24,887       25,743    
Income tax expense     571       542    
EBITDA     33,922       44,208    
Legal and professional fees (a)     2,177       104    
LIFO inventory valuation adjustments (b)     369       202    
Share-based compensation expense (c)     341       69    
Gain on sale of assets (d)     —       (11,014 )  
Other (e)     308       1,931    
Total adjustments to EBITDA     3,195       (8,708 )  
Adjusted EBITDA   $ 37,117     $ 35,500    

Notes:

(a) Legal and professional fees related to the dispute and associated arbitration with the New York State Teamsters Conference Pension and Retirement Fund. (b) Eliminates the non-cash impact of last-in, first-out (“LIFO”) accounting, which represents the difference between certain inventories valued under the first-in, first-out (“FIFO”) inventory method and the LIFO inventory method. (c) Compensation costs related to stock option grants. (d) During January 2015, the Company sold pharmacy scripts and inventory related to 27 of its in-store pharmacy locations for cash proceeds of $14.9 million. The Company recognized a resulting gain on sale of assets of $11.0 million, net of the carrying value of sold inventory of $3.2 million and direct selling expenses of $0.7 million. (e) Other one-time items not related to recurring operations.  The amount for the 2015 period includes $1.0 million of severance and other non-recurring costs associated with the closure of 27 in-store pharmacies in January 2015.

 

For more information contact: David Langless, EVP & Chief Financial Officer Phone: (716) 635-5000 Email: dlangless@topsmarkets.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PPL's January Dividend Keeps Utility Appeal Intact

Updated Category News Views 50

A dividend notice is rarely thrilling, but it can still separate a steady utility from a story stock peddling fumes. PPL Corporation declared a quarterly common dividend of $0.2850 per share on Nov. 20, payable Jan. 4, 2027. Shareholders must be on the books by Dec. 10, 2026, to receive it. Plain vanilla stuff, yes. Still, plain vanilla is often precisely why utility...

Continue Reading
Label-Free Detection Has a Solid, Narrow Growth Lane

Updated Category News Views 20

Biologics labs are turning into a far better hunting ground for analytical equipment than the old, broad-brush research story suggests. Label-free detection is not a giant market, and nobody should dress it up as one. But the projected move from $0.58 billion in 2026 to $0.85 billion by 2031 points to a useful 8.1% annual growth lane, driven by work researchers genuinely...

Continue Reading
Stowers Brings a Transformation CTO Into Its Lab

Updated Category News Views 125

Data Has Become Lab Infrastructure Microscopes may get the glory, but the plumbing behind modern biology is increasingly digital, sprawling and unforgiving. That is why Stowers Institute for Medical Research appointing Brandon Mayer as vice president and chief technology officer on November 19, 2026, deserves more attention than the usual executive-shuffle treatment. This...

Continue Reading
Intel Investors Face January 12 Lead Plaintiff Deadline

Updated Category News Views 178

A Narrow Calendar Window Has Opened Intel holders have another legal deadline to put on the fridge, and this one is not a casual housekeeping item. A securities class action has been filed in the Northern District of California on behalf of investors who bought or acquired Intel shares between July 23, 2026, and October 29, 2026. The deadline to seek appointment as lead...

Continue Reading
FAA Funding Gridlock Raises Aviation Reliability Risk

Updated Category News Views 95

Friday’s radar and communications trouble delivered the sort of warning nobody in aviation can shrug off: the machinery behind the flight board is getting old, fragile, and far too dependent on people improvising around it. Thousands of flights were delayed or canceled when air traffic control facilities became unstable, according to the Southwest Airlines Pilots...

Continue Reading
Fervo’s 46% Slide Puts Geothermal Claims Under Fire

Updated Category News Views 162

A 46% haircut from an IPO price has a way of stripping the paint off a growth story. Fervo Energy closed at $14.33 after the October 6 report cited in Hagens Berman’s announcement, well below its $27 IPO price from last May. That does not prove the report is right. It does mean NASDAQ:FRVO investors are staring at questions that go straight to the economic spine of...

Continue Reading
Automus and Google Cloud Put Agents to Work on Oracle

Updated Category News Views 68

Oracle back offices are where shiny AI promises go to earn their keep, or get buried under a mountain of integrations. Automus Consulting’s newly announced collaboration with Google Cloud, unveiled November 20 at Oracle AI World, is aimed squarely at that messy middle. The firm wants to combine its Oracle implementation experience with Google Cloud infrastructure and...

Continue Reading
MemorialCare Adds AI Guardrails for Hidden Aneurysms

Updated Category News Views 141

A brain scan ordered for one reason can suddenly expose a risk nobody knew was sitting there. That is the sober promise behind MemorialCare Neuroscience Institute's rollout of Rapid Aneurysm, an artificial-intelligence tool embedded in qualifying CTA and MRA brain scans across its inpatient and outpatient network. MemorialCare says it is the first health system in Los...

Continue Reading
Zesty Takes Kubernetes Cost Control Into GPU Territory

Updated Category News Views 88

GPU waste has become the sort of cloud bill nobody wants to explain upstairs. A company buys scarce, expensive accelerators for AI work, then discovers that real workloads do not politely consume resources in neat, permanent blocks. Demand jumps, memory needs shift, and somebody either over-allocates to avoid trouble or under-allocates and gets ugly out-of-memory...

Continue Reading
Chicago Kertész Show Puts Photography's Quiet Giant First

Updated Category News Views 49

A fork, a plate, and a sharp eye can outlast plenty of louder art. Leica Gallery Chicago is putting that proposition on the wall with André Kertész: The Master, opening December 4, 2026 and running through January 17, 2027. More than thirty signature works is not a sprawling museum survey, and frankly that may be the point. Kertész did not need grand scale to make his...

Continue Reading

Top 5 Most Recently Viewed Articles

BingX Enhances Trading Experience with CScalp Integration

Updated Category News Views 197

BingX Introduces Enhanced Trading Features with CScalp BingX, a prominent name in the cryptocurrency exchange sphere, has recently announced its integration with CScalp, a powerful trading terminal designed for both cryptocurrency and futures traders. This collaboration aims to provide users with cutting-edge trading tools, significantly enhancing their overall trading...

Continue Reading
Moscow Stocks Decline: Insights into Market Performance

Updated Category News Views 106

Moscow Stocks Face a Decline In the latest trading sessions, Moscow stocks have shown a clear downturn, with certain sectors especially driving this trend. The shifting dynamics within these sectors have created a challenging environment for investors. Performance by Sector and Important Takeaways The Telecoms, Mining, and Power sectors have been particularly tough,...

Continue Reading
Innovative Collaboration between Precision for Medicine and PathAI

Updated Category News Views 389

Strategic Alliance for Advancing Clinical Trials In a groundbreaking announcement, Precision for Medicine and PathAI are collaborating to revolutionize clinical trials and biomarker discovery. This partnership is set to introduce the next generation of AI-powered pathology tools designed to enhance quality control in clinical research. Enhancing Clinical Research...

Continue Reading
Declining Brazil Orange Juice Exports: Key Insights & Trends

Updated Category News Views 279

Overview of Brazil's Orange Juice Export Decline Brazil's orange juice exports have faced a significant downturn, with a 19.7% decrease in the first half of the 2024/25 crop season compared to the same time last year, as reported by CitrusBR. This decline represents approximately 535,600 metric tons of juice exports during this period, according to industry data....

Continue Reading
Celebrating 25 Years of Innovation in Legal Marketing

Updated Category News Views 164

Celebrating Two and a Half Decades of Digital Marketing PaperStreet Web Design, a pioneer in legal marketing, proudly marks its 25th anniversary. Founded by attorney and visionary Peter Boyd in 2001, this agency began as a one-person endeavor and has evolved into a nationally recognized firm employing over 30 professionals. With a rich history of aiding more than 2,500...

Continue Reading